130 related articles for article (PubMed ID: 12187264)
1. Adenovirus mediated gelsolin gene therapy for orthotopic human bladder cancer in nude mice.
Sazawa A; Watanabe T; Tanaka M; Haga K; Fujita H; Harabayashi T; Shinohara N; Koyanagi T; Kuzumaki N
J Urol; 2002 Sep; 168(3):1182-7. PubMed ID: 12187264
[TBL] [Abstract][Full Text] [Related]
2. Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice.
Tanaka M; Sazawa A; Shinohara N; Kobayashi Y; Fujioka Y; Koyanagi T; Kuzumaki N
Cancer Gene Ther; 1999; 6(5):482-7. PubMed ID: 10505859
[TBL] [Abstract][Full Text] [Related]
3. [Tumor suppressive function of gelsolin].
Kuzumaki N; Tanaka M; Sakai N; Fujita H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1436-41. PubMed ID: 9309138
[TBL] [Abstract][Full Text] [Related]
4. [Gelsolin gene therapy using adenovirus vector for orthotopically implanted human urinary bladder carcinoma in nude mice].
Sazawa A
Hokkaido Igaku Zasshi; 2001 Jul; 76(4):263-71. PubMed ID: 11523117
[No Abstract] [Full Text] [Related]
5. Adenovirus-mediated gene therapy for bladder cancer in an orthotopic model using a dominant negative H-ras mutant.
Watanabe T; Shinohara N; Sazawa A; Takimoto M; Hashimoto A; Koyanagi T; Kuzumaki N
Int J Cancer; 2001 Jun; 92(5):712-7. PubMed ID: 11340577
[TBL] [Abstract][Full Text] [Related]
6. ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton.
Yuan X; Yu L; Li J; Xie G; Rong T; Zhang L; Chen J; Meng Q; Irving AT; Wang D; Williams ED; Liu JP; Sadler AJ; Williams BR; Shen L; Xu D
Cancer Res; 2013 Jun; 73(12):3625-37. PubMed ID: 23536558
[TBL] [Abstract][Full Text] [Related]
7. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.
Melquist JJ; Kacka M; Li Y; Malaeb BS; Elmore J; Baseman AG; Hsieh JT; Koeneman KS
Urol Oncol; 2006; 24(4):362-71. PubMed ID: 16818192
[TBL] [Abstract][Full Text] [Related]
8. Gelsolin: a candidate for suppressor of human bladder cancer.
Tanaka M; Müllauer L; Ogiso Y; Fujita H; Moriya S; Furuuchi K; Harabayashi T; Shinohara N; Koyanagi T; Kuzumaki N
Cancer Res; 1995 Aug; 55(15):3228-32. PubMed ID: 7614452
[TBL] [Abstract][Full Text] [Related]
9. Gelsolin, an Actin-Binding Protein: Bioinformatic Analysis and Functional Significance in Urothelial Bladder Carcinoma.
Alsofyani AA; Nedjadi T
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958747
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
Adam L; Black PC; Kassouf W; Eve B; McConkey D; Munsell MF; Benedict WF; Dinney CP
J Urol; 2007 May; 177(5):1900-6. PubMed ID: 17437845
[TBL] [Abstract][Full Text] [Related]
11. [Double-mutated oncolytic adenovirus combined with gemcitabine for treating an orthotopic nude mouse model of bladder cancer].
Wang H; Liu Z; Wang ZP; Li FY; Zhao Y; Chen GP; Li DC
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):412-7. PubMed ID: 24119899
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.
Wang F; Wang Z; Tian H; Qi M; Zhai Z; Li S; Li R; Zhang H; Wang W; Fu S; Lu J; Rodriguez R; Guo Y; Zhou L
Curr Gene Ther; 2012 Apr; 12(2):67-76. PubMed ID: 22384806
[TBL] [Abstract][Full Text] [Related]
13. Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.
Benedict WF; Tao Z; Kim CS; Zhang X; Zhou JH; Adam L; McConkey DJ; Papageorgiou A; Munsell M; Philopena J; Engler H; Demers W; Maneval DC; Dinney CP; Connor RJ
Mol Ther; 2004 Sep; 10(3):525-32. PubMed ID: 15336652
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated transfer of p53 and p16 inhibiting proliferating activity of human bladder cancer cell EJ in vitro and in vivo.
Zhu Z; Xing S; Lin C; Zeng F; Lu G; Fu M; Zhang X; Liang X; Wu M
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):324-6. PubMed ID: 12674770
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8.
Inoue K; Wood CG; Slaton JW; Karashima T; Sweeney P; Dinney CP
Oncol Rep; 2001; 8(5):955-64. PubMed ID: 11496299
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.
Zhai Z; Wang Z; Fu S; Lu J; Wang F; Li R; Zhang H; Li S; Hou Z; Wang H; Rodriguez R
Gene Ther; 2012 Nov; 19(11):1065-74. PubMed ID: 22218302
[TBL] [Abstract][Full Text] [Related]
17. The growth inhibitory effect of p21 adenovirus on human bladder cancer cells.
Hall MC; Li Y; Pong RC; Ely B; Sagalowsky AI; Hsieh JT
J Urol; 2000 Mar; 163(3):1033-8. PubMed ID: 10688044
[TBL] [Abstract][Full Text] [Related]
18. Villin-1 and Gelsolin Regulate Changes in Actin Dynamics That Affect Cell Survival Signaling Pathways and Intestinal Inflammation.
Roy S; Esmaeilniakooshkghazi A; Patnaik S; Wang Y; George SP; Ahrorov A; Hou JK; Herron AJ; Sesaki H; Khurana S
Gastroenterology; 2018 Apr; 154(5):1405-1420.e2. PubMed ID: 29274870
[TBL] [Abstract][Full Text] [Related]
19. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model.
Miyake H; Hara I; Hara S; Arakawa S; Kamidono S
Urology; 2000 Aug; 56(2):332-6. PubMed ID: 10925118
[TBL] [Abstract][Full Text] [Related]
20. [Gene therapy study on bladder cancer with recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter].
Yan ZJ; Cheng Y; Jiang JH; Hu JS; Shi XD
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):732-6. PubMed ID: 23157908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
